Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

509 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial.
Sartore-Bianchi A, Pietrantonio F, Lonardi S, Mussolin B, Rua F, Crisafulli G, Bartolini A, Fenocchio E, Amatu A, Manca P, Bergamo F, Tosi F, Mauri G, Ambrosini M, Daniel F, Torri V, Vanzulli A, Regge D, Cappello G, Marchiò C, Berrino E, Sapino A, Marsoni S, Siena S, Bardelli A. Sartore-Bianchi A, et al. Among authors: daniel f. Nat Med. 2022 Aug;28(8):1612-1618. doi: 10.1038/s41591-022-01886-0. Epub 2022 Aug 1. Nat Med. 2022. PMID: 35915157 Free PMC article. Clinical Trial.
Prognostic impact of early tumor shrinkage and depth of response in patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors.
Fucà G, Corti F, Ambrosini M, Intini R, Salati M, Fenocchio E, Manca P, Manai C, Daniel F, Raimondi A, Morano F, Corallo S, Prisciandaro M, Spallanzani A, Quarà V, Belli C, Vaiani M, Curigliano G, Cremolini C, De Braud F, Di Bartolomeo M, Zagonel V, Lonardi S, Pietrantonio F. Fucà G, et al. Among authors: daniel f. J Immunother Cancer. 2021 Apr;9(4):e002501. doi: 10.1136/jitc-2021-002501. J Immunother Cancer. 2021. PMID: 33849927 Free PMC article.
Bevacizumab-induced hypertension as a predictor of clinical outcome in metastatic colorectal cancer: An individual patient data-based pooled analysis of two randomized studies and a systematic review of the literature.
Lombardi P, Rossini D, Crespi V, Germani MM, Bergamo F, Pietrantonio F, Santini D, Allegrini G, Daniel F, Pagani F, Antoniotti C, Zaniboni A, Conca V, Latiano TP, Boccaccino A, Passardi A, Tamburini E, Masi G, Di Maio M, Cremolini C. Lombardi P, et al. Among authors: daniel f. Cancer Treat Rev. 2022 Feb;103:102326. doi: 10.1016/j.ctrv.2021.102326. Epub 2021 Dec 23. Cancer Treat Rev. 2022. PMID: 35016085
FOLFOXIRI and bevacizumab in patients with early-onset metastatic colorectal cancer. A pooled analysis of TRIBE and TRIBE2 studies.
Antoniotti C, Germani MM, Rossini D, Lonardi S, Pietrantonio F, Santini D, Marmorino F, Allegrini G, Daniel F, Raimondi A, Borelli B, Zaniboni A, Conca V, Abraham J, Spetzler D, Maiello E, Boccaccino A, Passardi A, Giordano M, Tamburini E, Korn MW, Masi G, Cremolini C. Antoniotti C, et al. Among authors: daniel f. Eur J Cancer. 2022 May;167:23-31. doi: 10.1016/j.ejca.2022.02.031. Epub 2022 Mar 30. Eur J Cancer. 2022. PMID: 35366570
Clinical impact of neutropenia and febrile neutropenia in metastatic colorectal cancer patients treated with FOLFOXIRI/bevacizumab: a pooled analysis of TRIBE and TRIBE2 studies by GONO.
Rossini D, Boccaccino A, Sbrana A, Daniel F, Borelli B, Raimondi A, Santini D, Conca V, Tomasello G, Caponnetto S, Marmorino F, Zaniboni A, Buonadonna A, Masi G, Lonardi S, Pietrantonio F, Falcone A, Antonuzzo A, Cremolini C. Rossini D, et al. Among authors: daniel f. ESMO Open. 2021 Dec;6(6):100293. doi: 10.1016/j.esmoop.2021.100293. Epub 2021 Oct 22. ESMO Open. 2021. PMID: 34689001 Free PMC article.
A Real-World Application of Liquid Biopsy in Metastatic Colorectal Cancer: The Poseidon Study.
Procaccio L, Bergamo F, Daniel F, Rasola C, Munari G, Biason P, Crucitta S, Barsotti G, Zanella G, Angerilli V, Magro C, Paccagnella S, Di Antonio V, Loupakis F, Danesi R, Zagonel V, Del Re M, Lonardi S, Fassan M. Procaccio L, et al. Among authors: daniel f. Cancers (Basel). 2021 Oct 13;13(20):5128. doi: 10.3390/cancers13205128. Cancers (Basel). 2021. PMID: 34680277 Free PMC article.
Prognostic and Predictive Role of Body Mass Index (BMI) in Metastatic Colorectal Cancer (mCRC): A Pooled Analisys of Tribe and Tribe-2 Studies by GONO.
Dell'Aquila E, Rossini D, Galletti A, Stellato M, Boccaccino A, Conca V, Germani MM, Bergamo F, Daniel F, Spagnoletti A, Provenzano L, Tomasello G, Zaniboni A, Buonadonna A, Fanchini L, Cupini S, Carlomagno C, Caponnetto S, Rapisardi S, Santini D. Dell'Aquila E, et al. Among authors: daniel f. Clin Colorectal Cancer. 2022 Sep;21(3):220-228. doi: 10.1016/j.clcc.2022.02.003. Epub 2022 Feb 19. Clin Colorectal Cancer. 2022. PMID: 35304089
Ramucirumab: the long and winding road toward being an option for mCRC treatment.
Debeuckelaere C, Murgioni S, Lonardi S, Girardi N, Alberti G, Fano C, Gallimberti S, Magro C, Ahcene-Djaballah S, Daniel F, Fassan M, Prenen H, Loupakis F. Debeuckelaere C, et al. Among authors: daniel f. Expert Opin Biol Ther. 2019 May;19(5):399-409. doi: 10.1080/14712598.2019.1600505. Epub 2019 Apr 16. Expert Opin Biol Ther. 2019. PMID: 30917706 Review.
509 results